Prandin Use Code Case Taken Up By High Court
The U.S. Supreme Court on Monday agreed to review Novo Nordisk AS' win in a patent dispute over diabetes drug Prandin, a decision generic-drug makers claim has made it easier for...To view the full article, register now.
Already a subscriber? Click here to view full article